Stay updated with breaking news from Jeff Heier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
11.03.2024 - Leadership Appointments Move Ocular Towards Being a Leader in Retinal Care Screening Underway in AXPAXLI Phase 3 SOL-1 Trial for Wet AMD Topline Clinical Data for AXPAXLI in Diabetic Retinopathy and PAXTRAVA in Glaucoma Expected in Q2 2024 Cash ...
Operator: Good day. Thank you for standing by. Welcome to the Third Quarter 2023 Ocular Therapeutix Earnings Conference Call. At this time, all participants are in a listen-only mode.
GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical stage...
(2022-06-01 | NDAQ:AGTC) AGTC Announces Age-Related Macular Degeneration Scientific Advisory Board
/PRNewswire/ -- Nanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today...